MAPK3 and myeloid leukemia: Consistent with our results, previous studies have shown that probiotics such as L. reuteri 6475 can suppress the ERK1/2 pathway in tumor necrosis factor-treated human myeloid leukemia-derived cells (69), and that a multispecies probiotic product increased the bcl-2 levels in constipated mice (70).